Clinical TrialID 6168
Tyrosine for Methamphetamine Dependence - 1
NCT00000322
Amphetamine-Related Disorders
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6168
- Evidence Id
- 6168
- Core Evidence Id
- 6168
- Source Clinical Trial Id
- 6150
- Herb2 Clinical Trial Id
- HBCT006150
- Nct Id
- NCT00000322
- Title
- Tyrosine for Methamphetamine Dependence - 1
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Amphetamine-Related Disorders
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT
- Intervention
- BEHAVIORAL: Tyrosine
- Intervention Allocation
- Randomized
- Intervention Model
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 89
- Outcome Measure
- Craving|Drug use|Retention|Functioning
- Sponsor Collaborator
- National Institute on Drug Abuse (NIDA)
- Funded By
- NIH
- Location
- Haight Ashbury Free Clinics, San Francisco, California, 94117, United States
- Other Id
- NIDA-10739-1|R01-10739-1
- Start Date
- 1997-04
- Primary Completion Date
- Completion Date
- 2001-12
- First Posted
- 1999-09-21
- Results First Posted
- Last Update Posted
- 2017-01-12
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00000322
- Title Cn
- Title En
- Tyrosine for Methamphetamine Dependence - 1
- Bilingual Status
- semi_complete